Search for: "L Oreal USA Products, Inc. "
Results 41 - 47
of 47
Sorted by Relevance
|
Sort by Date
2 Feb 2012, 8:30 am
L'Oreal USA, Inc., supra, 36 Cal.4th 1028, 1042, and other cases. [read post]
6 Sep 2007, 4:29 pm
L'Oreal USA, Inc. 406 F.3d 905 (7th Cir.2005), which -- like the trial court in the James Brown case -- was the second decision on that appeal and which, upon a motion for rehearing, reached the opposite result from the original decision. [read post]
21 Jun 2009, 10:00 pm
(China Law Blog) Europe ECJ issues preliminary ruling in L’Oreal/Bellure regarding whether imitation perfumes were protected as permissible comparative advertising (Class 46) (IPKat) CFI: Proof of trade mark use: Harwin International LLC v OHIM, Cuadrado SA (IPKat) CFI: Last minute reprieve for passing off: Last Minute Network v OHIM-Last Minute Tour (IPKat) CFI dismisses Korsch’s appeal against refusal to grant CTM for ‘PharmaResearch’ due… [read post]
17 Apr 2008, 10:39 am
L'Oreal USA, Inc., 458 F.3d 244, 256 n. 5 (3d Cir. 2006). [read post]
20 Feb 2009, 5:00 am
(IPKat) AG’s opinion in L’Oreal v Bellure: unfair advantage aspects; IBIL seminar materials online (IPKat) Forthcoming attractions at the ECJ (IPKat) ISP liability, copyright term extension key IP issues for Europe this year (Intellectual Property Watch) Extension of copyright on audio recordings from 50 to 95 years passed through Legal Affairs Committee (TorrentFreak) (Managing Intellectual Property) EU, not content to double music copyrights, now looks to… [read post]
6 Jul 2009, 8:48 am
(Excess Copyright) (Michael Geist) Hill Times features op-ed by Michael Geist concerning copyright lobby recycling (Michael Geist) Owner of Glo Salon and Spa sues former employees now working at competitor for $6.4 million in damages over alleged misappropriation of trade secrets in the form of client lists and client colour cards (IP Osgoode) Federal court issues practice direction aimed at streamlining complex litigation (International Law Office) China Get involved in Chinese IP policy… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
